Tag: Prescription Drugs

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy

Severe exacerbation occurred in fewer patients receiving albuterol-budesonide versus those receiving albuterol only

Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours

Patients with HSV-1 who used antiherpetics were less likely to develop Alzheimer disease than those who did not

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy

Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia

Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity

Pausing Medicaid eligibility determinations during COVID-19 pandemic linked to increased risk for having no prescriptions and cash-pay prescriptions

Patients in the earliest stage of Alzheimer disease, with very mild symptoms, experienced the lowest risk of complications

However, increased risk of self-harm is seen before initiation of treatment, during initial phase of treatment, and after discontinuation